Results 171 to 180 of about 869,083 (311)

Targeting TM4SF1 exhibits therapeutic potential via inhibition of cancer stem cells

Signal Transduction and Targeted Therapy, 2022
Guang Chen, Xiaofei She, Yanxin Yin, Junxian Ma, Yaqun Gao, Hua Gao, Huanlong Qin, Jianmin Fang   +7 more
doaj   +1 more source

Lipocalin-2 and intestinal diseases. [PDF]

World J Gastroenterol
Zhang ZX, Peng J, Ding WW.
europepmc   +1 more source

Twinning as a risk factor for neonatal acute intestinal diseases: a case-control study. [PDF]

Front Pediatr, 2023
Peila C, Spada E, Riboldi L, Capitanio M, Pellegrino F, Coscia A.   +5 more
europepmc   +1 more source

Vestibular Patient Journey: Insights From Vestibular Disorders Association (VeDA) Registry

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Vestibular symptoms impose a high burden of disability. Understanding real‐world diagnostic and treatment pathways can identify care gaps and guide interventions. We aimed to characterize symptom profiles, diagnostic trends, provider involvement, and treatment patterns in vestibular disorders.
Ali Rafati, Sami I. Nassar, Shaun A. Nguyen, Patricia L. Gerend, Michael C. Schubert, Michael T. Teixido, Frederick A. Godley, Joel A. Goebel, Cynthia A. Ryan, Habib G. Rizk, Amir Kheradmand   +10 more
wiley   +1 more source

Meteorological factors, air pollution, and hospitalization rates of intestinal diseases. [PDF]

Medicine (Baltimore)
Wang J, Wang F, Li X, Li D, Liu Y, Li J, Liu Z, Liu J, Tang L.   +8 more
europepmc   +1 more source

High Concordance of CT Colonography and Colonoscopy Allows for the Distinguishing and Diagnosing of Intestinal Diseases. [PDF]

Life (Basel), 2023
Chervenkov L, Sirakov N, Georgiev A, Miteva D, Gulinac M, Peshevska-Sekulovska M, Sekulovski M, Velikova T.   +7 more
europepmc   +1 more source

A Prospective Study of Individuals at Risk of Multiple Sclerosis Informs the Design of Primary Prevention Studies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective In multiple sclerosis, the optimal time for deploying a therapeutic intervention is before the central nervous system is damaged; given the success of trials treating the earliest stage of MS, the radiologically isolated syndrome, developing primary prevention strategies is an important next challenge.
Amy W. Laitinen, Ceren Tozlu, Tina Roostaei, Fatoumata Diallo, Kaho Onomichi, Jiyeon Son, Zongqi Xia, Philip L. De Jager   +7 more
wiley   +1 more source

Causality relationship between 91 inflammatory factors and 5 intestinal diseases: A two-sample bidirectional Mendelian randomized study. [PDF]

Medicine (Baltimore)
Yuan X, Wang T, Wang T.
europepmc   +1 more source

The emerging roles of bacterial proteases in intestinal diseases. [PDF]

Gut Microbes, 2023
Caminero A, Guzman M, Libertucci J, Lomax AE.   +3 more
europepmc   +1 more source

Epilepsy‐Associated Variants of a Single SCN1A Codon Exhibit Divergent Functional Properties

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Pathogenic variants in SCN1A, which encodes the voltage‐gated sodium channel NaV1.1, are associated with multiple epilepsy syndromes exhibiting a range of clinical severity. SCN1A variants are reported in different syndromes, including Dravet syndrome, which is associated with loss‐of‐function, whereas neonatal/infantile‐onset ...
Lanie N. Liebovitz, Christopher H. Thompson, Linda C. Laux, Alfred L. George Jr.   +3 more
wiley   +1 more source